IMC Chicago’s Aspen Aerogels ASPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$346K Sell
54,500
-3,200
-6% -$15.7K ﹤0.01% 5061
2026
Q1
$197K Sell
57,700
-43,000
-43% -$145K ﹤0.01% 5024
2025
Q4
$285K Sell
100,700
-1,500
-1% -$7.74K ﹤0.01% 3831
2025
Q3
$711K Buy
102,200
+13,100
+15% +$92.4K ﹤0.01% 2950
2025
Q2
$527K Buy
89,100
+6,100
+7% +$35.1K ﹤0.01% 2828
2025
Q1
$530K Sell
83,000
-34,400
-29% -$332K ﹤0.01% 2619
2024
Q4
$1.39M Buy
117,400
+59,300
+102% +$1.01M ﹤0.01% 2131
2024
Q3
$1.61M Buy
58,100
+25,900
+80% +$648K ﹤0.01% 1801
2024
Q2
$768K Buy
32,200
+12,300
+62% +$289K ﹤0.01% 2103
2024
Q1
$350K Buy
+19,900
New +$293K ﹤0.01% 2187

Other funds holding ASPN

IMC Chicago's ASPN Position: Q2 2026 in Review

IMC Chicago sold out of Aspen Aerogels (ASPN) in Q2 2026, closing a stake of 22,470 shares — an estimated $110K sold.

IMC Chicago first reported a position in ASPN in Q2 2024 and held it in 8 quarters. The position peaked at $1.45M in Q4 2024. 179 funds tracked by Wall St. Rank hold ASPN as of Q2 2026.

  • IMC Chicago reported no remaining Aspen Aerogels position as of Q2 2026 after selling out during the quarter.
  • IMC Chicago sold 22,470 Aspen Aerogels shares in Q2 2026, an estimated $110K.
  • IMC Chicago first reported a position in Aspen Aerogels in Q2 2024 and held it in 8 quarters.
  • IMC Chicago's Aspen Aerogels position peaked at $1.45M in Q4 2024.
  • 179 funds tracked by Wall St. Rank held Aspen Aerogels as of Q2 2026.

Based on IMC Chicago's 13F filing for Q2 2026, filed 6 Aug 2026.